ATRY Stock Overview
A biomedical company, provides diagnostic services and medical treatments.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
Atrys Health, S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €3.96 |
52 Week High | €5.90 |
52 Week Low | €2.77 |
Beta | 0.41 |
1 Month Change | 36.55% |
3 Month Change | 26.11% |
1 Year Change | -18.01% |
3 Year Change | -56.48% |
5 Year Change | -10.00% |
Change since IPO | 147.50% |
Recent News & Updates
Recent updates
Atrys Health, S.A.'s (BME:ATRY) 38% Share Price Surge Not Quite Adding Up
May 25Is Atrys Health, S.A. (BME:ATRY) Trading At A 44% Discount?
Sep 09The Returns At Atrys Health (BME:ATRY) Aren't Growing
Jun 27Returns On Capital Are Showing Encouraging Signs At Atrys Health (BME:ATRY)
Nov 26Atrys Health (BME:ATRY) Might Have The Makings Of A Multi-Bagger
Aug 12Did You Miss Atrys Health's (BME:ATRY) Whopping 387% Share Price Gain?
Feb 02Atrys Health, S.A. (BME:ATRY) Shares Could Be 33% Above Their Intrinsic Value Estimate
Dec 11Shareholder Returns
ATRY | ES Healthcare | ES Market | |
---|---|---|---|
7D | 2.1% | 0.9% | -0.2% |
1Y | -18.0% | 2.5% | 19.0% |
Return vs Industry: ATRY underperformed the Spanish Healthcare industry which returned 2.4% over the past year.
Return vs Market: ATRY underperformed the Spanish Market which returned 18.7% over the past year.
Price Volatility
ATRY volatility | |
---|---|
ATRY Average Weekly Movement | 6.4% |
Healthcare Industry Average Movement | 4.9% |
Market Average Movement | 3.2% |
10% most volatile stocks in ES Market | 7.0% |
10% least volatile stocks in ES Market | 1.2% |
Stable Share Price: ATRY's share price has been volatile over the past 3 months.
Volatility Over Time: ATRY's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Spanish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 1,865 | Isabel Lozano Fernandez | www.atryshealth.com |
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.
Atrys Health, S.A. Fundamentals Summary
ATRY fundamental statistics | |
---|---|
Market cap | €300.70m |
Earnings (TTM) | -€30.45m |
Revenue (TTM) | €206.10m |
1.5x
P/S Ratio-9.9x
P/E RatioIs ATRY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ATRY income statement (TTM) | |
---|---|
Revenue | €206.10m |
Cost of Revenue | €148.96m |
Gross Profit | €57.15m |
Other Expenses | €87.59m |
Earnings | -€30.45m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.40 |
Gross Margin | 27.73% |
Net Profit Margin | -14.77% |
Debt/Equity Ratio | 76.1% |
How did ATRY perform over the long term?
See historical performance and comparison